Shareholders are advised of the following information relating to the dealings in securities by associates of directors of the company.
Name of associate | Slabbert Family Limited |
Name of director | Martin Slabbert, who has an indirect beneficial interest in Slabbert Family Limited, the entity which entered into the transaction |
Transaction date | 2 November 2012 |
Class of securities | Letters of allocation (JSE code NEPN) |
Number of securities | 297 325 |
Price per security | R3.40 |
Total value | R1 010 905 |
Nature of transaction | On-market sale |
Nature and extent of director’s interest | Indirect beneficial |
Name of associate | Slabbert Family Limited |
Name of director | Martin Slabbert, who has an indirect beneficial interest in Slabbert Family Limited, the entity which entered into the transaction |
Transaction date | 5 November 2012 |
Class of securities | Letters of allocation (JSE code NEPN) |
Number of securities | 86 693 |
Price per security | R3.00 |
Total value | R260 079 |
Nature of transaction | On-market sale |
Nature and extent of director’s interest | Indirect beneficial |
Name of associate | Focus CEE Investments Limited |
Name of director | Victor Semionov, who is a shareholder of Focus CEE Investments Limited, the entity which entered into the transaction |
Transaction date | 2 November 2012 |
Class of securities | Letters of allocation (JSE code NEPN) |
Number of securities | 93 675 |
Price per security | R3.40 |
Total value | R318 495 |
Nature of transaction | On-market sale |
Nature and extent of director’s interest | Indirect beneficial |
Name of associate | Focus CEE Investments Limited |
Name of director | Victor Semionov, who is a shareholder of Focus CEE Investments Limited, the entity which entered into the transaction |
Transaction date | 5 November 2012 |
Class of securities | Letters of allocation (JSE code NEPN) |
Number of securities | 27 313 |
Price per security | R3.00 |
Total value | R81 939 |
Nature of transaction | On-market sale |
Nature and extent of director’s interest | Indirect beneficial |